Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare histological variant of glioblastoma (WHO grade IV) with a predominance of bizarre, multinucleated giant cells, an occasionally abundant stromal reticulin network, and a high frequency of TP53 mutations. (WHO)
Biomarker and diagnostic research for giant cell glioblastoma has been reported in the published literature.
1 clinical trial registered. Interventions under study include drug therapy and other interventions. Pipeline includes 1 PHASE1. Research is primarily sponsored by academic and government institutions.
109 publications have been identified in PubMed for giant cell glioblastoma. Research spans Review / Meta-Analysis (47%), Basic Science / Preclinical (29%), and Gene Therapy / Novel Therapeutics (11%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 48 |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 3:47 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research | 30 | 29% |
New treatment approaches | 11 | 11% |
Testing and diagnosis research | 5 | 5% |
Other research | 4 | 4% |
Patient case studies | 3 | 3% |
Disease patterns and progression | 1 | 1% |
Zhang X (2026). [PMID: 42189411](https://pubmed.ncbi.nlm.nih.gov/42189411/). *Discov Oncol*. [Diagnostic / Biomarker]
Soumbasis A (2026). [PMID: 41310975](https://pubmed.ncbi.nlm.nih.gov/41310975/). *Brain*. [Review / Meta-Analysis]
Yao ZG (2026). [PMID: 41782063](https://pubmed.ncbi.nlm.nih.gov/41782063/). *Acta Neuropathol Commun*. [Basic Science / Preclinical]
Tang W (2026). [PMID: 41231102](https://pubmed.ncbi.nlm.nih.gov/41231102/). *Autophagy*. [Basic Science / Preclinical]
Kant S (2026). [PMID: 41364525](https://pubmed.ncbi.nlm.nih.gov/41364525/). *JCI Insight*. [Basic Science / Preclinical]
Pouyan A (2025). [PMID: 40011944](https://pubmed.ncbi.nlm.nih.gov/40011944/). *Mol Cancer*. [Review / Meta-Analysis]
Politis A (2025). [PMID: 40368035](https://pubmed.ncbi.nlm.nih.gov/40368035/). *Crit Rev Oncol Hematol*. [Review / Meta-Analysis]
Hou J (2025). [PMID: 40743902](https://pubmed.ncbi.nlm.nih.gov/40743902/). *Phytomedicine*. [Basic Science / Preclinical]
Fu Y (2025). [PMID: 40255400](https://pubmed.ncbi.nlm.nih.gov/40255400/). *Front Immunol*. [Review / Meta-Analysis]
Ghosh N (2025). [PMID: 40375039](https://pubmed.ncbi.nlm.nih.gov/40375039/). *Apoptosis*. [Review / Meta-Analysis]